Oral Corticosteroid Exposure and Adverse Effects in Asthmatic Patients

PW Sullivan, VH Ghushchyan, G Globe, M Schatz. J Allergy Clin Immunol. 2018;141(1):110–116.e7 To examine the association between intermittent oral corticosteroid (OCS) use and adverse events (AEs) in patients with asthma. The study included patients with asthma aged ≥18 years. The sample had a mean age of 38 years and was predominantly female (66%). Patients with chronic obstructive pulmonary disease, chronic bronchitis, emphysema, cystic fibrosis, or any of the selected AEs during the baseline period were excluded. Data were obtained from a retrospective review of an insurance claims data set (MarketScan Claims Database) from January 2000 …